EASL invites you to watch this on-demand webinar bringing together leading experts from across Europe to explore why early detection of chronic liver disease must become a priority in primary care.
Through real-world experiences, the panel discusses how primary care professionals can integrate more efficient risk stratification and early detection approaches into everyday care pathways. The discussion also highlights the growing role of digital and AI supported tools, particularly as new therapeutic options for liver disease are emerging.
As health systems prepare to scale up case finding, referrals, and long-term management of people with liver fibrosis, an essential question remains, is primary care ready? This webinar examines current barriers, practical solutions, and what needs to change to ensure timely diagnosis without overwhelming referral pathways.
Key topics covered
-
The case for early detection of chronic liver disease in primary care
-
Practical use of risk stratification, blood-based scores, and non-invasive testing
-
Integrating digital decision support and AI enabled tools into clinical workflows
-
Building effective referral pathways between primary and specialist care
-
Preparing primary care for emerging treatments in metabolic liver disease
Moderator
-
Prof. Dr Jörn Schattenberg, Professor of Medicine, Department of Internal Medicine, Gastroenterology, Hepatology and Endocrinology, Saarland University Medical Centre (Germany)
Speakers
-
Professor Thomas Frese, President of WONCA Europe, Professor of General Practice, Martin Luther University Halle-Wittenberg (Germany)
-
Dr Craig Nicoll, General Practitioner, Springfield West Medical Centre, NHS Scotland (UK)
-
Prof. Dr Josep M. Vilaseca, General Practitioner, Past Treasurer of WONCA Europe, Associate Professor, University of Vic, Central Catalonia University (Spain)
-
Lisa Rice-Duek, RN, Project Manager, LIVER-AIM, ISGlobal (Spain)
About LIVER-AIM
This webinar is part of the LIVER-AIM series, a 5-year EU initiative co-funded by the Innovative Health Initiative. LIVER-AIM aims to address the silent epidemic of chronic liver disease by improving early detection through biomarker-based risk stratification and large-scale evaluation across European populations.
Watch the webinar on demand and register to receive updates from the LIVER-AIM initiative.